← Back to homepage
Neutral
AstraZeneca holds talks with Bristol Myers Squibb on $400bn megadeal
Sources
2
Coverage
Limited spectrum
Sentiment
+0.30
◀ Left 50%Centre 50%Right 0% ▶
How we rate bias →This story is currently only covered by 2 sources from a limited part of the political spectrum. NewsDeck will update this page automatically if other outlets pick up the story.
NewsDeck Poll
Do you think this story is being covered fairly across the political spectrum?
Loading…
Left
(1)
Guardian Business
AstraZeneca holds talks with Bristol Myers Squibb on $400bn merger
Tie-up would be one of the biggest pharmaceutical deals ever and create the world’s fourth-largest drugmaker
Business live – latest updates
Britain’s biggest drugmaker AstraZeneca is in discussions to take over its US rival Bristol Myers Squibb in a deal that would create a near-$400bn (£300bn) pharmaceutical group.
AstraZeneca, run by longtime chief executive Pascal Soriot, is the second-biggest listed company in…
3 Aug, 07:08
Centre
(1)
FT UK
AstraZeneca holds talks with Bristol Myers Squibb on $400bn megadeal
Tie-up would create one of the world’s biggest drugmakers
2 Aug, 18:30
Right
(0)
No coverage from this perspective yet